The Antiseptic Efficacy and Tolerability of Lavasept® 0.04% on Acute Traumatic Wounds
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to assess the antiseptic efficacy of Lavasept 0.04%
when used as an antiseptic agent and to compare these with Ringers' solution in patients with
acute traumatic wounds.
Phase:
Phase 4
Details
Lead Sponsor:
B. Braun Ltd. Centre of Excellence Infection Control
Treatments:
Anti-Infective Agents, Local Pharmaceutical Solutions Polihexanide Polyhexamethylene biguanide